Newtyn Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.6M | Buy |
|
|||||
|
2025
Q1 | $42.5M | Hold |
|
|||||
|
2024
Q4 | $44.8M | Buy |
|
|||||
|
2024
Q3 | $36.3M | Buy |
|
|||||
|
2024
Q2 | $18M | Buy |
|
|||||
|
2024
Q1 | $14.7M | Sell |
|
|||||
|
2023
Q4 | $21.4M | Buy |
|
|||||
|
2023
Q3 | $15.9M | Buy |
|
|||||
|
2023
Q2 | $17M | Buy |
|
|||||
|
2023
Q1 | $16.6M | Buy |
|
|||||
|
2022
Q4 | $16.3M | Sell |
|
|||||
|
2022
Q3 | $25.3M | Buy |
|
|||||
|
2022
Q2 | $18.5M | Buy |
|
|||||
|
2022
Q1 | $13.1M | Buy |
|
|||||
|
2021
Q4 | $11.1M | Buy |
|
|||||
|
2021
Q3 | $725K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $4.49M | Buy |
|
|||||
|
2019
Q3 | $1.24M | Buy |
|